Mini-hyper-CVD with low-dose inotuzumab ozogamicin is an effective induction strategy for adults with immunomodulatory drug-associated B-cell acute lymphoblastic leukemia

Leukemia Research · Elsevier

Аннотация

Publication date: December 2026 Source: Leukemia Research, Volume 171 Author(s): Leora Boussi, Ettaib El Marabti, Brian Shaffer, Heather Landau, Yanming Zhang, Wenbin Xiao, Mikhail Roshal, Aaron D. Goldberg, Eytan M. Stein, Jae H. Park, Mark B. Geyer

Читать у издателя →

Похожие статьи